[Erysipelas. Retrospective study of 647 patients]

Tunis Med. 2004 Nov;82(11):990-5.
[Article in French]

Abstract

We conducted a retrospective at the department of dermatology of Charles Nicolle hospital of Tunis between January 1994 and December 2000 to determine the epidemiological, clinical profile and the evolution of erysipelas. A total of 647 patients were studied. The mean age was 44.73 years and sex ratio about 1.55. Erysipelas predominately involved in the lower limbs (91.2%). Antecedents of erysipelas were found in 26.12 %. Portal of entry was found in 76.66% represented essentially by toe-web intertrigo. 26.6% of patients were hospitalised. Erysipelas can be controlled with antibiotics; treatment is essentially based on penicillin G 4 mega units intramuscularly every day (60.58%) for mean duration of 10.13 days. Satisfying results were observed in 87.78%. Erysipelas is common disease source of over-morbidity. Many predisposing factors were incriminated, account for the frequency of recurrence, justifying implement of primary and secondary prevention.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Data Interpretation, Statistical
  • Erysipelas* / diagnosis
  • Erysipelas* / drug therapy
  • Erysipelas* / epidemiology
  • Erysipelas* / prevention & control
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Penicillin G / administration & dosage
  • Penicillin G / therapeutic use
  • Pregnancy
  • Primary Prevention
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Seasons
  • Sex Factors
  • Treatment Outcome
  • Tunisia / epidemiology

Substances

  • Anti-Bacterial Agents
  • Penicillin G